Results 71 to 80 of about 12,140,521 (311)
How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU
British Journal of Clinical Pharmacology, EarlyView.The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley +1 more source
Dynamics of health insurance ownership in Vietnam, 2004 – 06 [PDF]
Vietnam is undertaking health financing reform in an attempt to achieve universal health insurance coverage by 2014. Changes in health insurance policies have doubled the overall coverage between 2004 and 2006.
Trong-Ha Nguyen, Suiwah Leung
core
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
British Journal of Clinical Pharmacology, EarlyView.CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
British Journal of Clinical Pharmacology, EarlyView.Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer +4 more
wiley +1 more source
Digital health reimbursement: A scoping review of global lessons and policy implications
Digital HealthBackground Digital health technologies have expanded access to healthcare services by improving disease management and reducing unnecessary hospitalizations.
Reza Rabiei, Sohrab Almasi
doaj +1 more source
Annual report 2005 - The Health Insurance Authority
, 2006 The Health Insurance Authority ...
Health Insurance Authority, The
core
British Journal of Clinical Pharmacology, EarlyView.Aim To assess the impact of parameter settings when using the individualized dispensing patterns (IDP) method to estimate exposure duration from dispensing data. Methods We conducted a cohort study using a 2% representative sample of the French healthcare insurance database from 2013 to 2022.
Laëtitia Gosselin +8 more
wiley +1 more source
Journal of the Pakistan Medical AssociationObjective:To explore the experiences of key stakeholders, including hospital managers, clinicians, and hospital-based State Life Insurance Corporation (SLIC) representatives, SCP's implementation challenges and successes.
Shifa Salman Habib +8 more
doaj +1 more source
Social Health Insurance for the Poor Programs of the Philippines and Vietnam [PDF]
This paper compares the design features and implementation of the social health insurance (SHI) for the poor programs of the Philippines and Vietnam. The National Health Insurance Program-Sponsored Program of the Philippines and the Health Care Fund for ...
Capuno, Joseph J.
core
British Journal of Clinical Pharmacology, EarlyView.Aims GLP‐1 medicines provide substantial cardio‐renal benefits for type 2 diabetes (T2D) and are increasingly used for weight loss. Most high‐income countries subsidize access for T2D with restrictions; use outside of these restrictions occurs through private prescriptions. Despite strong consumer demand, the extent of private access to GLP‐1 medicines
Michael O. Falster +10 more
wiley +1 more source